Non-Current Assets

Goodwill

Biogen Goodwill decreased by 0.0% to $6.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.2%, from $6.48B to $6.49B. Over 5 years (FY 2020 to FY 2025), Goodwill shows an upward trend with a 2.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026

How to read this metric

A significant increase indicates recent M&A activity, while a sudden decrease typically signals an impairment charge due to underperforming acquisitions.

Detailed definition

Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...

Peer comparison

Standard metric for companies that grow through acquisition; comparable across all industries.

Metric ID: goodwill

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$5.76B$5.76B$5.76B$5.76B$5.75B$5.74B$5.75B$5.75B$5.75B$6.81B$6.22B$6.23B$6.23B$6.49B$6.48B$6.48B$6.49B$6.49B$6.49B$6.49B
QoQ Change-0.1%+0.0%-0.1%-0.1%-0.1%+0.1%+0.0%+0.0%+18.3%-8.6%+0.1%+0.0%+4.1%-0.1%-0.0%+0.2%-0.0%+0.0%-0.0%
YoY Change-0.2%-0.3%-0.2%-0.1%+0.1%+18.6%+8.2%+8.3%+8.2%-4.7%+4.2%+4.0%+4.3%+0.1%+0.2%+0.2%
Range$5.74B$6.81B
CAGR+2.5%
Avg YoY Growth+3.2%
Median YoY Growth+0.2%

Frequently Asked Questions

What is Biogen's goodwill?
Biogen (BIIB) reported goodwill of $6.49B in Q1 2026.
How has Biogen's goodwill changed year-over-year?
Biogen's goodwill increased by 0.2% year-over-year, from $6.48B to $6.49B.
What is the long-term trend for Biogen's goodwill?
Over 5 years (2020 to 2025), Biogen's goodwill has grown at a 2.4% compound annual growth rate (CAGR), from $5.76B to $6.49B.
What does goodwill mean?
The excess price paid for an acquisition over the fair value of its net assets.